Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.30
-0.01-0.76%
At close: -
$1.33
0.032.31%
After Hours: 4:32 PM EDT
Comments
Loading...
Sonnet BioTherapeutics Stock Price, Quotes and Forecasts
SONNNASDAQ
Sonnet BioTherapeutics (SONN) Forecast
NewsEarningsSonnet BioTherapeutics (SONN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sonnet BioTherapeutics Stock Price, Quotes and Forecasts | NASDAQ:SONN | Benzinga
Explore Sonnet BioTherapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SONN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Sonnet BioTherapeutics (SONN) stock?
You can purchase shares of Sonnet BioTherapeutics (NASDAQ:SONN) through any online brokerage.
Who are Sonnet BioTherapeutics (SONN) competitors?
Other companies in Sonnet BioTherapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Galecto (NASDAQ:GLTO), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX) and Synaptogenix (NASDAQ:SNPX).
What is the forecast, or price target, for Sonnet BioTherapeutics (SONN) stock?
Sonnet BioTherapeutics has a consensus price target of $10.18.
What is the current price for Sonnet BioTherapeutics (SONN)?
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $1.33 last updated May 20, 2025 at 4:32 PM EDT.
Does Sonnet BioTherapeutics (SONN) pay a dividend?
There are no upcoming dividends for Sonnet BioTherapeutics.
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics’s Q3 earnings are confirmed for Wednesday, August 13, 2025.
Is Sonnet BioTherapeutics (SONN) going to split?
There is no upcoming split for Sonnet BioTherapeutics.
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
